Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma].

No shinkei geka. Neurological surgery - 1 Feb 2012

Kamoshima Yuuta, Motegi Hiroaki, Terasaka Shunsuke, Kobayashi Hiroyuki, Yamaguchi Shigeru, Murata Junichi, Tanaka Shinya, Houkin Kiyohiro

Abstract excerpt

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor with an extremely poor prognosis in spite of multimodal treatment approaches. The median survival time of patients with GBM is 15 months, and only 3-5% of patients survive longer than 36 months. Those patients who survive over 36 months after the initial diagnosis are defined as long-term survivors. In this study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Modification Methylases

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Survivors

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 22281465

Genes

IDH1
MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma].PMID 22281465Read ↗

[A clinical and molecular study of long-term survival glioblastomas].Semantic proximity Read ↗

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant GlioblastomaSemantic proximity Read ↗

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.Semantic proximity Read ↗

Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.Semantic proximity Read ↗

Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.Semantic proximity Read ↗

Aggressive Treatment in Glioblastoma: What Determines the Survival of Patients?Semantic proximity Read ↗

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factorSemantic proximity Read ↗

IDH1 mutation of gliomas with long-term survival analysis.Semantic proximity Read ↗

The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.Semantic proximity Read ↗

[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].Semantic proximity Read ↗

Clinical Impact of <i>IDH1</i> Mutations and <i>MGMT</i> Methylation in Adult Glioblastoma MultiformeSemantic proximity Read ↗

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.